SAM
GWPH

Solaris Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Solaris Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-250
Closed -$33K – 201
2017
Q4 		$33K Hold
250
– – 0.02% 185
2017
Q3 		$25K Hold
250
– – 0.01% 206
2017
Q2 		$25K Buy
+250
New +$26.9K 0.02% 214

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Solaris Asset Management's GWPH Position: Q1 2018 in Review

Solaris Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2018, closing a stake of 250 shares — an estimated $33K sold.

Solaris Asset Management first reported a position in GWPH in Q2 2017 and held it in 3 quarters. The position peaked at $33K in Q4 2017. 191 funds tracked by Wall St. Rank hold GWPH as of Q1 2018.

  • Solaris Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
  • Solaris Asset Management sold 250 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2018, an estimated $33K.
  • Solaris Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2017 and held it in 3 quarters.
  • Solaris Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $33K in Q4 2017.
  • 191 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2018.

Based on Solaris Asset Management's 13F filing for Q1 2018, filed 16 Apr 2018.